Tamura, N., Horinouchi, H., Sekine, K., Matsumoto, Y., Murakami, S., Goto, Y., . . . Ohe, Y. (2019). Efficacy of subsequent docetaxel +/− ramucirumab and S‐1 after nivolumab for patients with advanced non‐small cell lung cancer. Thorac Cancer.
Citação norma ChicagoTamura, Nobumasa, et al. "Efficacy of Subsequent Docetaxel +/− Ramucirumab and S‐1 After Nivolumab for Patients With Advanced Non‐small Cell Lung Cancer." Thorac Cancer 2019.
Citação norma MLATamura, Nobumasa, et al. "Efficacy of Subsequent Docetaxel +/− Ramucirumab and S‐1 After Nivolumab for Patients With Advanced Non‐small Cell Lung Cancer." Thorac Cancer 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.